What Are Complications of Using Riboflavin–UV-A Corneal Collagen Cross-Linking to Treat Keratoconus?
March 15, 2011
The March 2011 issue of the Archives of Ophthalmology reports on research investigating complications from using riboflavin–UV-A corneal collagen cross-linking (CXL) to treat keratoconus.
Prior research has identified stromal haze formation and permanent stromal haze as complications of CXL (albeit the cases involved relatively mild haze and eyes with advanced keratoconus).
Click here to access the article.
You might also enjoy...
- What is Long Term Success Rate of Corneal Transplants to Treat Keratoconus?
- Is Photorefractive Keratectomy Followed By Corneal Collagen Cross-Linking Effective in Treating Keratoconus?
- Gene Therapy Safe and Effective Treatment for Common Form of Leber Congenital Amaurosis
- Is PRK or Other Surgery an Option to Treat a Mild Corneal Scar That Impairs Vision?
- What Are Risks of Cataract Surgery After Corneal Transplants?
Comments
Jump down to form below to submit your own comments
One Response to “What Are Complications of Using Riboflavin–UV-A Corneal Collagen Cross-Linking to Treat Keratoconus?”
Trackback URL
http://eyedocnews.com/005010-what-are-complications-of-using-riboflavin%e2%80%93uv-a-corneal-collagen-cross-linking-to-treat-keratoconus/trackback/
Have insights to contribute? Please submit your comment below
Wow thanks for this information I am about to get a keratoconus treatment done and now will be looking into it more after reading this. Thanks!